Antimicrobial Hydrogel Dressings Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: June 30, 2023 Report Code: GDME1554EPD-ST

Select Item

Antimicrobial Hydrogel Dressings Pipeline Market Report Overview

Antimicrobial hydrogel dressings are hydrogel dressings impregnated with an agent that inhibits microbial growth. One unit refers to one hydrogel dressing.

The antimicrobial hydrogel dressings pipeline market research report provides comprehensive information about the antimicrobial hydrogel dressings pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories The US, Europe, and the United Kingdom
Key Regulatory Paths 510(k), CE, PMA, UKCA
Leading Companies CelaCare Technologies LLC, Edixomed Ltd, Gel4Med Inc, In2cure AB, Institute of Nano Science and Technology, Novyx Technologies LLC, O2 Regentech LLC, Plurogen Therapeutics Inc (Inactive), Quick-Med Technologies Inc, Smith & Nephew Plc, and Syracuse University
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Antimicrobial Hydrogel Dressings Pipeline Market Segmentation by Territories

Some of the territories in the antimicrobial hydrogel dressings market are the United States (US), Europe, and the United Kingdom among others. As of June 2023, the United States had the highest number of pipeline products.

Antimicrobial Hydrogel Dressings Pipeline Market Analysis, by Territories, 2023 (%)

Antimicrobial Hydrogel Dressings Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the antimicrobial hydrogel dressings pipeline market, download a free report sample

Antimicrobial Hydrogel Dressings Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the antimicrobial hydrogel dressings pipeline market are 510(k), CE, PMA, and UKCA among others. As of June 2023, 510(k) was the most followed pathway for pipeline products.

Antimicrobial Hydrogel Dressings Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Antimicrobial Hydrogel Dressings Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the antimicrobial hydrogel dressings pipeline market, download a free report sample

Antimicrobial hydrogel dressings Pipeline Market – Competitive Landscape

Some of the key companies in the antimicrobial hydrogel dressings pipeline market are CelaCare Technologies LLC, Edixomed Ltd, Gel4Med Inc, In2cure AB, Institute of Nano Science and Technology, Novyx Technologies LLC, O2 Regentech LLC, Plurogen Therapeutics Inc (Inactive), Quick-Med Technologies Inc, Smith & Nephew Plc, and Syracuse University among others.

CelaCare Technologies LLC: The company offers OTC antimicrobial gel and caters the wound care management sector. OTC Antimicrobial Gel is a clear, spreadable gel intended for wound care management. It is designed to aid in the healing of wounds by exhibiting potent, broad-spectrum antimicrobial activity against a range of pathogens. It is based on CelaCare Technology. It provides enhanced functional properties that enable wound healing. The company also provides Prescription Gel 1 and Prescription Gel 2 as their key offering.

Segments Covered in the Report

Antimicrobial Hydrogel Dressings Pipeline Market Territories Outlook

  • The US
  • Europe
  • The United Kingdom

Antimicrobial Hydrogel Dressings Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • PMA
  • UKCA

Scope

  • Extensive coverage of the antimicrobial hydrogel dressings under development

  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities

  • Reviews the major players involved in the development of antimicrobial hydrogel dressings and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with the potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of antimicrobial hydrogel dressings under development

  • Develop market-entry and market-expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

CelaCare Technologies LLC
Edixomed Ltd
Gel4Med Inc
In2cure AB
Institute of Nano Science and Technology
Novyx Technologies LLC
O2 Regentech LLC
Plurogen Therapeutics Inc (Inactive)
Quick-Med Technologies Inc
Smith & Nephew Plc
Syracuse University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Antimicrobial Hydrogel Dressings Overview 8

3 Products under Development 9

3.1 Antimicrobial Hydrogel Dressings – Pipeline Products by Stage of Development 9

3.2 Antimicrobial Hydrogel Dressings – Pipeline Products by Territory 10

3.3 Antimicrobial Hydrogel Dressings – Pipeline Products by Regulatory Path 11

3.4 Antimicrobial Hydrogel Dressings – Pipeline Products by Estimated Approval Date 12

3.5 Antimicrobial Hydrogel Dressings – Ongoing Clinical Trials 13

4 Antimicrobial Hydrogel Dressings – Pipeline Products under Development by Companies 14

4.1 Antimicrobial Hydrogel Dressings Companies – Pipeline Products by Stage of Development 14

4.2 Antimicrobial Hydrogel Dressings – Pipeline Products by Stage of Development 15

5 Antimicrobial Hydrogel Dressings Companies and Product Overview 16

5.1 CelaCare Technologies LLC Company Overview 16

5.1.1 CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Edixomed Ltd Company Overview 19

5.2.1 Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Gel4Med Inc Company Overview 24

5.3.1 Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 In2cure AB Company Overview 26

5.4.1 In2cure AB Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Institute of Nano Science and Technology Company Overview 29

5.5.1 Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 Novyx Technologies LLC Company Overview 30

5.6.1 Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 30

5.7 O2 Regentech LLC Company Overview 31

5.7.1 O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 Plurogen Therapeutics Inc (Inactive) Company Overview 32

5.8.1 Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Quick-Med Technologies Inc Company Overview 35

5.9.1 Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.10 Smith & Nephew Plc Company Overview 36

5.10.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 Syracuse University Company Overview 37

5.11.1 Syracuse University Pipeline Products & Ongoing Clinical Trials Overview 37

6 Antimicrobial Hydrogel Dressings- Recent Developments 39

6.1 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 39

6.2 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 41

6.3 Mar 09, 2023: Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders 41

6.4 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 42

6.5 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 42

6.6 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 42

6.7 Sep 28, 2022: Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto 43

6.8 Sep 26, 2022: Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting 45

6.9 Aug 29, 2022: Covalon Announces Third Quarter Fiscal 2022 Results 47

6.10 Aug 01, 2022: Advanced Medical Solutions Group Announce Directorate Change 47

6.11 Jul 13, 2022: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results 48

7 Appendix 50

7.1 Methodology 50

7.2 About GlobalData 53

7.3 Contact Us 53

7.4 Disclaimer 53

Table

Antimicrobial Hydrogel Dressings – Pipeline Products by Stage of Development 9

Antimicrobial Hydrogel Dressings – Pipeline Products by Territory 10

Antimicrobial Hydrogel Dressings – Pipeline Products by Regulatory Path 11

Antimicrobial Hydrogel Dressings – Pipeline Products by Estimated Approval Date 12

Antimicrobial Hydrogel Dressings – Ongoing Clinical Trials 13

Antimicrobial Hydrogel Dressings Companies – Pipeline Products by Stage of Development 14

Antimicrobial Hydrogel Dressings – Pipeline Products by Stage of Development 15

CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 16

OTC Antimicrobial Gel – Product Status 16

OTC Antimicrobial Gel – Product Description 16

Prescription Gel 1 – Product Status 17

Prescription Gel 1 – Product Description 17

Prescription Gel 2 – Product Status 17

Prescription Gel 2 – Product Description 18

Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

EDX110 – Burns – Product Status 19

EDX110 – Burns – Product Description 19

EDX110 – Cystic Fibrosis – Product Status 20

EDX110 – Cystic Fibrosis – Product Description 20

EDX110 – Diabetic Foot Ulcer – Product Status 20

EDX110 – Diabetic Foot Ulcer – Product Description 21

EDX110 – Pressure Ulcers – Product Status 21

EDX110 – Pressure Ulcers – Product Description 21

EDX110 – Septic Shock – Product Status 22

EDX110 – Septic Shock – Product Description 22

EDX110 – Surgical Wounds – Product Status 22

EDX110 – Surgical Wounds – Product Description 23

EDX110 – Venous Leg Ulcers – Product Status 23

EDX110 – Venous Leg Ulcers – Product Description 23

Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview 24

G4db – Product Status 24

G4db – Product Description 24

G4I – Product Status 25

G4I – Product Description 25

In2cure AB Pipeline Products & Ongoing Clinical Trials Overview 26

TCP-25 – Product Status 26

TCP-25 – Product Description 26

In2cure AB – Ongoing Clinical Trials Overview 27

TCP-25 – A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male and Female Volunteers to Investigate the Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds 28

Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 29

Smart Injectable Hydrogel – Product Status 29

Smart Injectable Hydrogel – Product Description 29

Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 30

Hydrogel Wound Dressing – Product Status 30

Hydrogel Wound Dressing – Product Description 30

O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview 31

OXAID – Product Status 31

OXAID – Product Description 31

Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

PluroGel PNN – Product Status 32

PluroGel PNN – Product Description 32

Plurogen Therapeutics Inc (Inactive) – Ongoing Clinical Trials Overview 33

PluroGel PNN – A Between Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries 34

PluroGel PNN – A Within Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries 34

Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Nimbus Hydrogel – Product Status 35

Nimbus Hydrogel – Product Description 35

Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 36

Wound Dressing – Product Status 36

Wound Dressing – Product Description 36

Syracuse University Pipeline Products & Ongoing Clinical Trials Overview 37

Antimicrobial Hydrogel Web – Product Status 37

Antimicrobial Hydrogel Web – Product Description 37

Shape Memory Polymer Hydrogel – Product Status 38

Shape Memory Polymer Hydrogel – Product Description 38

Glossary 52

Figures

Antimicrobial Hydrogel Dressings – Pipeline Products by Stage of Development 9

Antimicrobial Hydrogel Dressings – Pipeline Products by Territory 10

Antimicrobial Hydrogel Dressings – Pipeline Products by Regulatory Path 11

Antimicrobial Hydrogel Dressings – Pipeline Products by Estimated Approval Date 12

Antimicrobial Hydrogel Dressings – Ongoing Clinical Trials 13

Frequently asked questions

Antimicrobial Hydrogel Dressings Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Antimicrobial Hydrogel Dressings Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Antimicrobial Hydrogel Dressings reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Antimicrobial Hydrogel Dressings Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Antimicrobial Hydrogel Dressings Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more